Bundle Blocks 2

Build actionable cancer patient-specific precision medicine treatment plans

Access the right clinical knowledge, nationally-recognized clinical standards, and genomic oncology expertise in real time.

  • Improve clinical decision-making
  • Align with genomic-guided medicine
  • Access to relevant clinical trials
  • Reduce cancer patient ER visits and hospitalization costs
  • Increase patient awareness and confidence in recommended treatment plan
  • Comply with nationally-recognized clinical standards
  • Improve overall care coordination

Bundle Blocks 1

First-of-its-kind Precision Medicine Planning Platform for OCM participants

Viviphi unveils its comprehensive pathway and cognitive computing platform which includes codified clinical rules in support of genomic-based targeted therapies, immunotherapies and complex combination treatments. PrecisionPlan™ will help participating cancer treatment providers meet The Center for Medicare and Medicaid Innovation’s (CMMI) new Oncology Care Model (OCM) requirements. 

The Viviphi™  platform will be available to OCM participants in January 2017 as the 5-year value-based care funding pilot moves from the planning phase to implementation. 

The Viviphi™ platform was designed as a true 21st century clinical peer-to-peer knowledge transfer platform where physicians can get immediate access to standards of care and expert knowledge pertaining to genomic-based targeted and immunotherapies personalized to the specific patient being treated.

Bundle Blocks 2

Viviphi and Avera Health Confirm Clinical Validation and System-Wide Implementation of the PrecisionPlan™ Cognitive Computing Platform

Viviphi and Avera Health recently announced that the PrecisionPlan™ platform will be fully implemented across the multi-state cancer system. The platform was developed through a clinical collaboration in precision medicine between the two organizations.

PrecisionPlan™ is a cognitive computing platform that generates comprehensive, actionable and patient-specific treatment plans in a matter of seconds. The artificial intelligence solution combines patient-specific diagnostic, surgical and demographic data from the electronic medical record (EMR) with genomic and tumor sequencing information to generate personalized treatment plans that comply with nationally respected evidence and the latest clinical guidance in precision medicine.

Matt's Story

Matt is a 6-time lung cancer survivor because of genomic testing and a personalized treatment strategy.

As the Founder/CEO of SURVIVEiT®, he believes it is vital for patients to take control of their care and develop a treatment plan that is specific to their cancer.

Learn more about Matt’s personal battle with cancer and his passion for helping patients to advocate for the best care available.

Know What is Driving Your Cancer

Dr. Brian Leyland-Jones explains why each cancer patient must insist on having his or her tumor sequenced to find out what genetic alterations are driving his or her cancer.

When you know the genomics behind your cancer and the treatments available, you can work with your doctor to determine a treatment strategy specific to you.

GenomePlan™ is your personalized treatment plan to help you beat cancer.

Viviphi News